Achieve Life Sciences, Inc. Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31)
Achieve Life Sciences, Inc. (ACHV) had Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) of $94.30 million as of 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost · last filed 2012-08-02
- 2012-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $94.30M.
- 2011-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $74.12M.
| Period end | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) |
|---|---|
| 2012-06-30 | $94.30M 10-Q · filed 2012-08-02 |
| 2011-06-30 | $74.12M 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |